Re: your message

Found some medical usage data for cannabis. Remember research of cannabis is illeagal in the US (stiff jail term) so much data is inconclusive. But this much we do know.

CANNABIS

· Class

analgesic, antiemetic, antiglaucoma agent

· Dosage, Adult (usual)
APPETITE STIMULATION, oral: 2.5 to 5 milligrams (mg) of dronabinol daily
CHEMOTHERAPY-INDUCED NAUSEA/VOMITING, capsule, oral: 5 milligrams/meter squared (mg/m(2)) given 1 to 3 hours prior to chemotherapy administration. It should then be given every 2 to 4 hours after chemotherapy for a total of 4 to 6 doses daily.
CHEMOTHERAPY-INDUCED NAUSEA/VOMITING, cigarette, inhalation: 5 to 12.5 milligrams THC per meter squared

· Dosage, Pediatric, (usual)
CHEMOTHERAPY-INDUCED NAUSEA/VOMITING, capsule, oral: 5 mg/m(2) given 1 to 3 hours prior to chemotherapy administration. It should then be given every 2 to 4 hours after chemotherapy for a total of 4 to 6 doses daily.

· Administration
oral, injection, solution, aerosol, cigarettes

· How Supplied
tablet, capsule, ocular solution, cigarettes

· Indications
Tourette syndrome (possibly effective)
alcoholism (inconclusive)
anorexia (effective)
anxiety (possibly effective)
bronchodilation/asthma (possibly effective)
cancer (inconclusive)
depression (inconclusive)
fertility (ineffective)
fungus (in vitro data)
glaucoma (effective)
headache (possibly effective)
infection (in vitro data)
inflammation (animal data)
morphine abstinence (animal data)
muscle relaxant (possibly effective)
nausea/vomiting (adult, effective; pediatric, effective)
pain (inconclusive)
phobic states (animal data)
sedative/hypnotic (inconclusive)
seizures (inconclusive)

· Contraindications
hypersensitivity to Cannabis or any of its components
hypersensitivity to sesame seed oil if taking dronabinol
use of dronabinol is contraindicated in patients whose nausea and vomiting is due to reasons other than cancer chemotherapy

· Adverse Effects
altered sensorium, psychoses
blurred vision
cognitive impairment
decreased coordination
decreased motivation
dizziness
dry mouth and eyes
hallucinations
heart rate changes
hypotension, hypertension
mood changes
respiratory allergy
sedation
short term memory loss
skin rash
somnolence
tolerance, withdrawal symptoms
urinary retention

· Drug Interactions
anticholinergic agents
barbiturates
calamus
central nervous system depressants
cocaine
disulfiram
ethanol
protease inhibitors
selective serotonin reuptake inhibitors
sildenafil
theophylline
tricyclic antidepressants

Pregnancy
do not use during pregnancy

Lactation
do not use during lactation

CANNABIS

THERAPEUTIC USES
ALCOHOLISM
ANOREXIA
ANXIETY
BRONCHODILATION/ASTHMA
CANCER
DEPRESSION
FERTILITY
FUNGUS
GLAUCOMA
HEADACHE
INFECTION
INFLAMMATION
MORPHINE ABSTINENCE
MUSCLE RELAXANT
NAUSEA/VOMITING
PAIN
PHOBIC STATES
PRURITUS, CHOLESTASIS-ASSOCIATED
SEDATIVE/HYPNOTIC
SEIZURES
SPASTICITY
TOURETTE SYNDROME

MICROMEDEX(R) Healthcare Series Vol. 121 expires 9/2004